We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Handheld Pen Enables Real-Time Tissue Identification during Surgery

By LabMedica International staff writers
Posted on 30 Aug 2023

Thyroid and parathyroid gland surgeries pose significant challenges, even for experienced surgeons. More...

These relatively small neck structures share characteristics like color and texture, complicating visual differentiation. For instance, during thyroid removal procedures, accidental parathyroid removal occurs in about 25% of cases. Similarly, unsuccessful parathyroid removals often result from the inability to locate and resect diseased parathyroid tissue, as thyroid nodules and lymph nodes can be mistaken for parathyroid tissue. There is a critical need for innovative methods to preserve healthy tissue and ensure precise resection.

In a new project, surgeons at Baylor College of Medicine (Houston, TX, USA) extensively tested the MasSpec Pen during thyroid and parathyroid surgeries. In the operating room, the MasSpec Pen helps surgeons identify tissues for resection before actually performing the procedure, ensuring accurate tissue removal without unnecessary damage. Integrating seamlessly into the surgical workflow, the pen can be sterilized like other instruments and simply connected to the mass spectrometer. Its intuitive use holds immense potential for saving time during surgery. The pen primarily detects small molecules like metabolites (cell metabolism byproducts) and lipids created by cells. Each tissue has a unique metabolite and lipid pattern. While many molecules are similar across tissues, their concentrations vary based on tissue type, enabling surgeons to differentiate tissues. The process is simple: the surgeon places the pen gently on the tissue, which deposits a droplet of room-temperature sterile water, extracting small molecules. The droplet is then directed to a real-time mass spectrometer that reveals the tissue's molecular composition, indicating its type. Importantly, this procedure does not harm the analyzed tissues.

In order to assess the precision of this novel technology, the scientists conducted a comparison between the tissue identification outcomes produced by the MasSpec Pen and the well-established method of tissue identification—pathology analysis. Pathologists are experts who specialize in microscopically discerning tissue samples. The MasSpec Pen exhibited exceptional accuracy in distinguishing thyroid, parathyroid, and lymph node tissues during surgeries, achieving accuracy rates exceeding 90%. Results from the MasSpec Pen analysis were available in around 20 seconds, whereas processing samples for pathology analysis (referred to as frozen section) during surgery can extend to an hour, thus saving both procedure time and cost. Typically, prolonged surgeries heighten the risk of complications. The use of the MasSpec Pen offers the benefit of real-time tissue identification during surgical procedures, enhancing patient care.

“The MasSpec Pen could be applied to surgeries of other organs, such as lungs or pancreas,” said co-corresponding author Dr. James Suliburk, associate professor of surgery and member of the Dan L Duncan Comprehensive Cancer Center at Baylor College of Medicine. “We think this can really revolutionize how we do surgery.”

Related Links:
Baylor College of Medicine


Gold Member
Clinical Chemistry Assay
Sorbitol Dehydrogenase (SDH)
Online QC Software
Acusera 24•7
Multi-Chamber Washer-Disinfector
WD 390
Clinical Informatics Platform
CLARION™
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Characterization of EV separated by distinct methods (Photo courtesy of Yuanyuan Liu, Yanbin Guo et al. Engineering, doi.org/10.1016/j.eng.2025.12.009)

Liquid Biopsy Biomarkers May Improve Childhood Epilepsy Diagnosis

Childhood epilepsy remains a major neurological disorder with unmet needs for accurate, non-invasive biomarkers, as conventional tests such as electroencephalography and neuroimaging can have limited sensitivity... Read more

Molecular Diagnostics

view channel
Image: MCD tests are designed to detect multiple cancers from a single blood sample, but the statements note that evaluating these assays is far more complex than assessing single-cancer tests (image credit: Adobe Stock)

Position Statements Outline Evidence Standards for Multi-Cancer Detection Tests

Cancer screening is intended to reduce mortality, but policy decisions often depend on early indicators that may not fully reflect true survival benefit. The emergence of blood-based tests capable of detecting... Read more

Pathology

view channel
Image: Immune-related signals in routine bone marrow biopsy slides could help predict multiple myeloma outcomes and support more personalized treatment strategies (image credit: Shutterstock)

AI Tool Extracts Immune Signals from Biopsy to Inform Myeloma Therapy

Multiple myeloma is a bone marrow malignancy in which patients can respond very differently to the same treatments, making initial therapy decisions difficult. Clinicians must choose among options such... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.